Abstract
The question of whether some blood vessels in tumors of non-vascular origin are lined by cancer cells has been discussed for many years because of the relevance to metastasis, access of drugs to tumor cells, and the effectiveness of angiogenesis inhibitors. Most evidence favoring the existence of tumor cell-lined vessels has come from observations of standard histopathological tissue sections or from transmission and scanning electron microscopic studies. However, it has been difficult to determine convincingly just how abundant these vessels are in tumors. On the one hand, virtually the entire microvasculature is supposedly lined by tumor cells in aggressive uveal melanomas, assuming the presence of vasculogenic mimicry where tumor cells masquerading as endothelial cells create the channels for blood flow. On the other hand, morphometric studies using immunohistochemistry and green fluorescent protein-transfected tumor cells suggest that human colon cancer cells constitute only 3% of the vessel surface in tumors grown orthotopically in mice. This commentary weighs evidence that cancer cells are located in the wall of tumor vessels and discusses the pitfalls in identifying such vessels. Published data along with new observations illustrate the challenges of making an unequivocal identification of tumor cells in vessel walls. Taken together, current evidence suggests that cancer cells contribute at most only a small proportion of the lining of blood vessels in tumors and may be migrating through vessel walls or exposed by defects in the endothelium. Even in aggressive uveal melanomas, blood flow probably occurs mainly through channels lined by endothelial cells, not tumor cells, and most existing data do not support a functionally significant contribution of vasculogenic mimicry. Innovative new approaches that distinguish pleomorphic tumor cells from abnormal endothelial cells in vessel walls will help to define the incidence and importance of tumor cell-lined blood vessels in drug delivery and metastasis via the bloodstream.
Similar content being viewed by others
References
Willis RA: Pathology of Tumours. Butterworth & Co., Ltd., London, 1948
Franç ois J: Malignant melanomata of the choroid. Montgomery Memorial Lecture 1961. Br J Ophthalmol 47: 736-743, 1963
Jensen OA: Malignant melanoma of the choroid of a peculiar cavernous type. Arch Ophthalmol 72: 337-340, 1964
Duke-Elder S, Perkins ES: Cysts and tumours of the uveal tract. In: Duke-Elder S (ed) System of Ophthalmology, 1 edn, Vol IX. Diseases of the Uveal Tract, C.V. Mosby Company, St. Louis, 1966, pp 754-937
Franç ois J, Neetens A: Physico-anatomical studies of spontaneous and experimental intraocular newgrowths: vascular supply. Bibl Anat 9: 403-411, 1967
Jensen OA: The 'Knapp-Rø nne' type of malignant melanoma of the choroid: a haemangioma-like melanoma with a typical clinical picture. So-called 'preretinal malignant choroidal melanoma'. Acta Ophthalmol (Copenh) 54: 41-54, 1976
Warren BA, Shubik P: The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 15: 464-478, 1966
Warren BA: The vascular morphology of tumors. In: Peterson H-I (ed) Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors, CRC Press, Inc., Boca Raton, 1979, pp 1-48
Prause JU, Jensen OA: Scanning electron microscopy of frozen-cracked, dry-cracked and enzyme-digested tissue of human malignant choroidal melanomas. Albrecht Von Graefes Arch Klin Exp Ophthalmol 212: 217-225, 1980
Hammersen F, Endrich B, Messmer K: The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis. Int J Microcirc Clin Exp 4: 31-43, 1985
Konerding MA, Steinberg F, Streffer C: The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies. Acta Anat (Basel) 136: 27-33, 1989
Nasu R, Kimura H, Akagi K, Murata T, Tanaka Y: Blood flow influences vascular growth during tumour angiogenesis. Br J Cancer 79: 780-786, 1999
Chang YS, diTomaso E, Roberge S, McDonald DM, Jain RK, Munn LL: Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc Am Assoc Cancer Res 41: 2000
Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658, 1988
Vaupel P, Kallinowski F, Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465, 1989
Majno G, Joris I: Cells, Tissue, and Disease: Principles of General Pathology, Blackwell Science, Cambridge, MA, 1996, p 786, Figure 27.9
Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752, 1999
Folberg R, Hendrix MJC, Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156: 361-381, 2000
McDonald DM, Munn L, Jain RK: Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156: 383-388, 2000
Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM: Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133: 95-109, 1988
Less JR, Skalak TC, Sevick EM, Jain RK: Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 51: 265-273, 1991
Kohn S, Nagy JA, Dvorak HF, Dvorak AM: Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 67: 596-607, 1992
Konerding MA, Miodonski AJ, Lametschwandtner A: Microvascular corrosion casting in the study of tumor vascularity: a review. Scanning Microsc 9: 1233-1243; discussion 1243-1244, 1995
Less JR, Posner MC, Skalak TC, Wolmark N, Jain RK: Geometric resistance and microvascular network architecture of human colorectal carcinoma. Microcirculation 4: 25-33, 1997
Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM: Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156: 1363-1380, 2000
Papadimitrou JM, Woods AE: Structural and functional characteristics of the microcirculation in neoplasms. J Pathol 116: 65-72, 1975
Steinberg F, Konerding MA, Streffer C: The vascular architecture of human xenotransplanted tumors: histological, morphometrical, and ultrastructural studies. J Cancer Res Clin Oncol 116: 517-524, 1990
Vermeulen PB, Verhoeven D, Fierens H, Hubens G, Goovaerts G, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY: Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer 71: 340-343, 1995
Hewitt RE, Powe DG, Morrell K, Balley E, Leach IH, Ellis IO, Turner DR: Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast. Br J Cancer 75: 221-229, 1997
Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG: Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60: 1388-1393, 2000
Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK: Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612, 1998
Van den Brenk HA, Crowe M, Kelly H, Stone MG: The significance of free blood in liquid and solid tumours. Br J Exp Pathol 58: 147-159, 1977
Schechter JE, Felicio LS, Nelson JF, Finch CE: Pituitary tumorigenesis in aging female C57BL/6J mice: a light and electron microscopic study. Anat Rec 199: 423-432, 1981
Liwnicz BH, Wu SZ, Tew Jr JM: The relationship between the capillary structure and hemorrhage in gliomas. J Neurosurg 66: 536-541, 1987
Schechter J, Ahmad N, Elias K, Weiner R: Estrogen-induced tumors: changes in the vasculature in two strains of rat. Am J Anat 179: 315-323, 1987
Specht CS, McLean IW, Biscoe BW: Traumatic enucleation for posterior uveal melanoma. Am J Ophthalmol 110: 518-521, 1990
Meis-Kindblom JM, Kindblom LG: Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 22: 683-697, 1998
Cheng SY, Nagane M, Huang HS, Cavenee WK: Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci USA 94: 12 081-12 087, 1997
De Dobbeleer G, Godfrine S, Andre J, Ledoux M, De Maubeuge J: Clinically uninvolved skin in AIDS: evidence of atypical dermal vessels similar to early lesions observed in Kaposi's sarcoma. Ultrastructural study in four patients. J Cutan Pathol 14: 154-157, 1987
Bosman C, Bisceglia M, Quirke P: Ultrastructural study of Kaposi's sarcoma. Pathologica 88: 8-17, 1996
Thurston G, McLean JW, Rizen M, Baluk P, Haskell A, Murphy TJ, Hanahan D, McDonald DM: Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 101: 1401-1413, 1998
Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, Jain RK: Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res 52: 6553-6560, 1992
Boucher Y, Leunig M, Jain RK: Tumor angiogenesis and interstitial hypertension. Cancer Res 56: 4264-4266, 1996
Gazit Y, Baish JW, Safabakhsh N, Leunig M, Baxter LT, Jain RK: Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation 4: 395-402, 1997
Mueller AJ, Freeman WR, Folberg R, Bartsch DU, Scheider A, Schaller U, Kampik A: Evaluation of microvascularization pattern visibility in human choroidal melanomas: comparison of confocal fluorescein with indocyanine green angiography. Graefe's Arch Clin Exp Ophthalmol 237: 448-456, 1999
Hanahan D, Christofori G, Naik P, Arbeit J: Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 32A: 2386-2393, 1996
Berger R, Albelda SM, Berd D, Ioffreda M, Whitaker D, Murphy GF: Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo. J Cutan Pathol 20: 399-406, 1993
Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, Thorpe PE: Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1: 1623-1634, 1995
Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR: Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107: 233-235, 1995
Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct alpha v integrins. Science 270: 1500-1502, 1995
Risau W: Mechanisms of angiogenesis. Nature 386: 671-674, 1997
Brekken RA, Huang X, King SW, Thorpe PE: Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res 58: 1952-1959, 1998
Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1998, 1999
Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154: 1381-1390, 1999
Kim S, Bell K, Mousa SA, Varner JA: Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol 156: 1345-1362, 2000
Thorpe PE, Burrows FJ: Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treat 36: 237-251, 1995
Arap W, Pasqualini R, Ruoslahti E: Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279: 377-380, 1998
Gong MC, Chang SS, Sadelain M, Bander NH, Heston WDW: Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers. Cancer Metastasis Rev 18: 483-490, 1999
Pasqualini R: Vascular targeting with phage peptide libraries. Q J Nucl Med 43: 159-162, 1999
Bredow S, Lewin M, Hofmann B, Marecos E, Weissleder R: Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. Eur J Cancer 36: 675-681, 2000
Fonsatti E, Jekunen AP, Kairemo KJ, Coral S, Snellman M, Nicotra MR, Natali PG, Altomonte M, Maio M: Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res 6: 2037-2043, 2000
Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL: Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 60: 3088-3095, 2000
Miettinen M, Lindenmayer AE, Chaubal A: Endothelial cell markers CD31, CD34, and BNH9 antibody to H-and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7: 82-90, 1994
DeYoung BR, Swanson PE, Argenyi ZB, Ritter JH, Fitzgibbon JF, Stahl DJ, Hoover W, Wick MR: CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. J Cutan Pathol 22: 215-222, 1995
Orchard GE, Zelger B, Jones EW, Jones RR: An immunocytochemical assessment of 19 cases of cutaneous angiosarcoma. Histopathology 28: 235-240, 1996
Hellwig SM, Damen CA, van Adrichem NP, Blijham GH, Groenewegen G, Griffioen AW: Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors. Cancer Lett 120: 203-211, 1997
Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM, Bundred N: Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59: 856-861, 1999
de la Taille A, Katz AE, Bagiella E, Buttyan R, Sharir S, Olsson CA, Burchardt T, Ennis RD, Rubin MA: Microvessel density as a predictor of PSA recurrence after radical 119 prostatectomy. A comparison of CD34 and CD31. Am J Clin Pathol 113: 555-562, 2000
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164, 1994
Rabb H, Barroso-Vicens E, Adams R, Pow-Sang J, Ramirez G: Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney. Am J Nephrol 16: 402-408, 1996
Liapis H, Adler LM, Wick MR, Rader JS: Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum Pathol 28: 443-449, 1997
Max R, Gerritsen RR, Nooijen PT, Goodman SL, Sutter A, Keilholz U, Ruiter DJ, De Waal RM: Immunohistochemical analysis of integrin alphavbeta3 expression on tumor-associated vessels of human carcinomas. Int J Cancer 71: 320-324, 1997
Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R, Cheresh DA: Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 4: 2625-2634, 1998
Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL: Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res 60: 712-721, 2000
Martin-Padura I, De Castellarnau C, Uccini S, Pilozzi E, Natali PG, Nicotra MR, Ughi F, Azzolini C, Dejana E, Ruco L: Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol 175: 51-57, 1995
Lewalle JM, Bajou K, Desreux J, Mareel M, Dejana E, Noel A, Foidart JM: Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res 237: 347-356, 1997
McLean JW, Fox EA, Baluk P, Bolton PB, Haskell A, Pearlman P, Thurston G, Umemoto EY, McDonald DM: Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 273: H387-H404, 1997
Wang J, Yao A, Wang JY, Sung CC, Fink LM, Hardin JW, Hauer-Jensen M: cDNA cloning and sequencing, gene expression, and immunolocalization of thrombomodulin in the Sprague-Dawley rat. DNA Res 6: 57-62, 1999
Bohling T, Paetau A, Ekblom P, Haltia M: Distribution of endothelial and basement membrane markers in angiogenic tumors of the nervous system. Acta Neuropathol (Berl) 62: 67-72, 1983
Ordonez NG, Batsakis JG: Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions. Arch Pathol Lab Med 108: 129-132, 1984
Kuzu I, Bicknell R, Fletcher CD, Gatter KC: Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 69: 322-328, 1993
Maruno M, Yoshimine T, Isaka T, Kuroda R, Ishii H, Hayakawa T: Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains. J Neuro-Oncol 19: 155-160, 1994
Schadendorf D, Heidel J, Gawlik C, Suter L, Czarnetzki BM: Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 87: 366-371, 1995
Suzuki Y, Ohtani H, Mizoi T, Takeha S, Shiiba K, Matsuno S, Nagura H: Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res 86: 585-593, 1995
Mayer B, Spatz H, Funke I, Johnson JP, Schildberg FW: De novo expression of the cell adhesion molecule E-selectin on gastric cancer endothelium. Langenbecks Arch Surg 383: 81-86, 1998
Ye C, Kiriyama K, Mistuoka C, Kannagi R, Ito K, Watanabe T, Kondo K, Akiyama S, Takagi H: Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 61: 455-460, 1995
Kraling BM, Razon MJ, Boon LM, Zurakowski D, Seachord C, Darveau RP, Mulliken JB, Corless CL, Bischoff J: E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 148: 1181-1191, 1996
Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S, Brodt P: Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59: 1356-1361, 1999
Cervello M, Virruso L, Lipani G, Giannitrapani L, Soresi M, Carroccio A, Gambino R, Sanfililippo R, Marasa L, Montalto G: Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Cancer Res Clin Oncol 126: 345-351, 2000
Farmer RW, Richtsmeier WJ, Scher RL: Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Head Neck 20: 726-731, 1998
Tang DG, Chen YQ, Newman PJ, Shi L, Gao X, Diglio CA, Honn KV: Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem 268: 22 883-22 894, 1993
Tezuka Y, Yonezawa S, Maruyama I, Matsushita Y, Shimizu T, Obama H, Sagara M, Shirao K, Kusano C, Natsugoe S et al.: Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis. Cancer Res 55: 4196-4200, 1995
Ruck P, Xiao JC, Kaiserling E: Immunoreactivity of sinusoids in hepatoblastoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelium-associated antigens, including CD34. Histopathology 26: 451-455, 1995
Ordonez NG: Thrombomodulin expression in transitional cell carcinoma. Am J Clin Pathol 110: 385-390, 1998
Aroca F, Renaud W, Bartoli C, Bouvier-Labit C, Figarella-Branger D: Expression of PECAM-1/CD31 isoforms in human brain gliomas. J Neuro-Oncol 43: 19-25, 1999
Ogawa H, Yonezawa S, Maruyama I, Matsushita Y, Tezuka Y, Toyoyama H, Yanagi M, Matsumoto H, Nishijima H, Shimotakahara T, Aikou T, Sato E: Expression of thrombomodulin in squamous cell carcinoma of the lung: its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett 149: 95-103, 2000
Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP: Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337: 1584-1590, 1997
Holden CA, Spaull J, Das AK, McKee PH, Jones EW: The histogenesis of angiosarcoma of the face and scalp: an immunohistochemical and ultrastructural study. Histopathology 11: 37-51, 1987
Burgio VL, Zupo S, Roncella S, Zocchi M, Ruco LP, Baroni CD: Characterization of EN4 monoclonal antibody: a reagent with CD31 specificity. Clin Exp Immunol 96: 170-176, 1994
Nakamura S, Muro H, Suzuki S, Sakaguchi T, Konno H, Baba S, Syed AS: Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma. Hepatology 26: 407-415, 1997
Kaaya EE, Parravicini C, Ordonez C, Gendelman R, Berti E, Gallo RC, Biberfeld P: Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol 10: 295-305, 1995
Leenstra S, Troost D, Das PK, Claessen N, Becker AE, Bosch DA: Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease. Cancer 72: 3061-3067, 1993
de la Torre M, Nygren P, Larsson R, Lindgren A, Tsuruo T, Bergh J: Expression of the 85-kd membrane protein in primary human breast cancer: relationship to hormone receptor levels, DNA ploidy, and tumor grade. Hum Pathol 26: 180-185, 1995
Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, Knudsen B, Bander NH: Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res 57: 3629-3634, 1997
Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C: Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3: 81-85, 1997
Chang SS, O'Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB: Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 5: 2674-2681, 1999
Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB: Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59: 3192-3198, 1999
Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD: Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA 92: 4567-4571, 1995
Weiler-Guettler H, Aird WC, Husain M, Rayburn H, Rosenberg RD: Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus. Circ Res 78: 180-187, 1996
Guillot PV, Guan J, Liu L, Kuivenhoven JA, Rosenberg RD, Sessa WC, Aird WC: A vascular bed-specific pathway. J Clin Invest 103: 799-805, 1999
McDonald DM: Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol 266: L61-L83, 1994
Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC: The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 23: 1298-1305, 1992
Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM: The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100: 1389-1398, 1993
Luyten GP, Mooy CM, Post J, Jensen OA, Luider TM, de Jong PT: Metastatic uveal melanoma. A morphologic and immunohistochemical analysis. Cancer 78: 1967-1971, 1996
Nasu R, Kimura H, Akagi K, Murata T, Tanaka Y: Blood flow influences vascular growth during tumor angiogenesis. Br J Cancer 79: 780-786, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McDonald, D.M., Foss, A.J. Endothelial Cells of Tumor Vessels: Abnormal but not Absent. Cancer Metastasis Rev 19, 109–120 (2000). https://doi.org/10.1023/A:1026529222845
Issue Date:
DOI: https://doi.org/10.1023/A:1026529222845